We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+2.05%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$700M
AUM Growth
+$3.92M
Cap. Flow
+$12.1M
Cap. Flow %
1.73%
Top 10 Hldgs %
36.05%
Holding
81
New
2
Increased
31
Reduced
29
Closed
5

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$24.2M
2
PFE icon
Pfizer
PFE
+$16.3M
3
ICL icon
ICL Group
ICL
+$8.29M
4
JCI icon
Johnson Controls International
JCI
+$6.36M
5
FCX icon
Freeport-McMoran
FCX
+$6.23M

Top Sells

Rank Stock Value
1
BHI
Baker Hughes
BHI
+$8.25M
2
R icon
Ryder
R
+$7.84M
3
DD
Du Pont De Nemours E I
DD
+$7.79M
4
BG icon
Bunge Global
BG
+$6.98M
5
TDC icon
Teradata
TDC
+$5.14M

Sector Composition

Rank Sector Weight
1 Healthcare 25.81%
2 Financials 15.56%
3 Technology 12.94%
4 Consumer Staples 10.96%
5 Materials 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAG icon
1
Conagra Brands
CAG
$6.82B
$37.6M 5.37%
1,330,413
-33,950
-2% -$929K
PNC icon
2
PNC Financial Services
PNC
$99.3B
$29.5M 4.22%
323,614
-10,240
-3% -$888K
MDT icon
3
Medtronic
MDT
$105B
$27.8M 3.97%
384,589
-10,963
-3% -$762K
BAX icon
4
Baxter International
BAX
$11.1B
$24.7M 3.53%
621,223
+17,660
+3% +$688K
MET icon
5
MetLife
MET
$59.6B
$23.8M 3.4%
493,696
+2,365
+0.5% +$112K
MSFT icon
6
Microsoft
MSFT
$2.83T
$23.4M 3.35%
504,431
-11,095
-2% -$521K
VZ icon
7
Verizon
VZ
$184B
$23.1M 3.31%
+494,691
New +$24.2M
WBA
8
DELISTED
Walgreens Boots Alliance
WBA
$20.9M 2.99%
275,224
-34,594
-11% -$2.31M
TEVA icon
9
Teva Pharmaceuticals
TEVA
$36B
$20.9M 2.99%
626,002
+4,051
+0.7% +$226K
BG icon
10
Bunge Global
BG
$23.7B
$20.6M 2.94%
226,585
-79,281
-26% -$6.98M
APA icon
11
APA Corp
APA
$13B
$17.8M 2.55%
284,383
+32,202
+13% +$2.29M
MOS icon
12
The Mosaic Company
MOS
$7.06B
$17.5M 2.49%
382,517
+16,178
+4% +$717K
CHKP icon
13
Check Point Software Technologies
CHKP
$13.1B
$17.4M 2.48%
220,945
-17,517
-7% -$1.3M
FCX icon
14
Freeport-McMoran
FCX
$91.1B
$17M 2.43%
728,691
+225,685
+45% +$6.23M
STT icon
15
State Street
STT
$50.7B
$16.9M 2.42%
215,726
-234
-0.1% -$17.6K
PFE icon
16
Pfizer
PFE
$142B
$16.8M 2.4%
+568,297
New +$16.3M
AVT icon
17
Avnet
AVT
$7.34B
$16.2M 2.32%
376,880
-5,720
-1% -$242K
COV
18
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$16.2M 2.31%
158,286
+28,109
+22% +$2.7M
JNJ icon
19
Johnson & Johnson
JNJ
$622B
$15.9M 2.27%
151,815
+690
+0.5% +$72.7K
JCI icon
20
Johnson Controls International
JCI
$87.7B
$15.1M 2.16%
299,228
+130,109
+77% +$6.36M
MAT icon
21
Mattel
MAT
$4.15B
$14.4M 2.05%
463,869
+71,530
+18% +$2.2M
TDW icon
22
Tidewater
TDW
$3.84B
$14.3M 2.04%
13,659
+1,322
+11% +$1.5M
PPL
23
PPL Corp
PPL
$27.3B
$13.5M 1.93%
398,644
+55,570
+16% +$1.82M
TUP
24
DELISTED
Tupperware Brands Corporation
TUP
$12.8M 1.83%
202,787
-4,445
-2% -$290K
ICL icon
25
ICL Group
ICL
$6.83B
$12.4M 1.76%
1,703,719
+1,186,020
+229% +$8.29M

Similar funds

Foyston, Gordon, & Payne's Q4 2014 Portfolio in Review

As of Q4 2014, Foyston, Gordon, & Payne held 81 positions worth $700M, up 0.56% from $696M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Foyston, Gordon, & Payne's Q4 2014 filing shows 2 new, 31 increased, 29 reduced and 5 closed positions. Its largest new stake was Verizon: 494,691 shares worth $23.1M. The largest sale was Baker Hughes, an estimated $8.25M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

  • Foyston, Gordon, & Payne's largest Q4 2014 buy was Verizon: 494,691 shares worth $23.1M.
  • Foyston, Gordon, & Payne added most to ICL Group in Q4 2014, an estimated $8.29M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2014 reduction was Baker Hughes, cutting an estimated $8.25M.
  • Foyston, Gordon, & Payne fully exited Ryder in Q4 2014, selling an estimated $7.84M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 36% of its $700M portfolio in Q4 2014.
  • Foyston, Gordon, & Payne opened 2 new positions and closed 5 in Q4 2014.
  • Foyston, Gordon, & Payne's portfolio value rose 0.56% quarter-over-quarter to $700M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2014, filed 13 Feb 2015.